Objective: The aim of the study was to examine the efficacy of an unguided, self-help cognitive behavior therapy (SH-CBT) booklet on hot flush and night sweat (HFNS) problem rating, delivered in a work setting.
W ith rising employment rates for women and an aging profile of the workforce in the United Kingdom and most European countries, increasing numbers of women will be working during their menopausal transition and postmenopause. 1, 2 As a result there is growing interest in improving the health and well-being of working women, and retaining and increasing the numbers of experienced older women in the workplace. Recent recommendations and guidance also stress the importance of improving the experience of menopause for working women. [3] [4] [5] There are over 3.5 million women in employment aged between 50 and 65 years in the United Kingdom 6 and, given that menopause (final menstruation) occurs on average between the ages of 50 to 51 and the menopausal transition can last for up to 10 years, 7 a significant proportion of female workers will be experiencing menopausal symptoms. Although many women go through menopause with few problems, approximately 20% to 30% have troublesome symptoms that impact their quality of life. 8, 9 Hot flushes and night sweats (HFNS) are the main menopausal symptoms and these are particularly difficult to manage in work contexts, due to physical discomfort, social embarrassment, and the effects of disturbed sleep. 10 As well as hot flushes, women have been found to report that tiredness, memory/concentration, and loss of confidence are problematic at work. 11 Women are generally reluctant to disclose their menopause status, particularly at work, where embarrassment and fear of ridicule is common, and self-control is highly valued. Hot flushes may draw attention to menopause status, particularly during formal meetings, when working with men and/or younger adults or in hot environments. 10, 12, 13 Discussion about menopause at work is widely perceived as taboo 14 and consequently, despite women's reported experiences, there is a lack of awareness about menopause in work settings.
Although an under-researched area, several cross-sectional studies have examined the impact of work environment on experience of menopause, as well as the impact of menopause upon work performance. There is some evidence that menopausal symptoms can have an effect on work experience, for example, perceived performance, and that certain work situations and physical working environments, such as aspects of work design and temperature, and work stress, can increase the intensity of menopausal symptoms. 11, [15] [16] [17] [18] [19] [20] [21] However, Jack et al in a recent systematic review 22 concluded that although some working women who had bothersome menopausal symptoms reported impaired work outcomes, the overall evidence was inconclusive. Moreover, surveys of workrelated stress in the United Kingdom 23 suggest that women aged 45 to 54 years report more work-related stress than midaged men or women of any other age group. There are likely to be complex relationships between work-related stress and the experience of menopausal symptoms. 24 Griffiths et al 11 conducted a study of 896 women employed in 10 UK-based organizations. Women suggested several areas requiring organizational change to improve women's experience of menopause at work; these included: (i) greater awareness among managers about menopause as a possible occupational health issue, (ii) flexible working hours, (iii) access to information and sources of support at work, and (iv) attention to work place temperature and ventilation. The present study aims to address (iii) as outlined in the study protocol paper. 25 Hormone therapy (HT) is an effective medical treatment for menopausal symptoms 26 but not all women want to take it due to contraindications and personal preference. Cognitive behavior therapy (CBT) is recommended for anxiety and depression during menopause 26 and a CBT intervention has been developed to help women to manage HFNS, [27] [28] [29] [30] that is based on a theoretical model 31 supported by recent empirical studies. [32] [33] [34] HFNS can be potentiated by stress and are exacerbated by negative beliefs and behavioral reactions. The intervention therefore includes psychoeducation and evidence-based CBT strategies to reduce stress, and to manage hot flushes, night sweats, and sleep. CBT for HFNS has been found to be effective in reducing the impact of HFNS, that is, how problematic they are, in several clinical trials, 27-29 frequency of night sweats, 27 and physiologically monitored HFNS. 35 CBT was recommended as an effective treatment for vasomotor symptoms in a recent position statement on nonhormonal interventions by The North American Menopause Society. 36 Group CBT and SH-CBT (a SH booklet containing the same information with a breathing/relaxation CD) formats for HFNS have been shown to be equally effective in reducing the impact of HFNS 27 ; however, group CBT had more impact on mood and quality of life. SH-CBT has also been found to produce similar levels of improvement when delivered with minimal guidance. 30 Although CBT interventions for HFNS are available in SH and group formats, 37, 38 there have not been any previous work-based trials and CBT interventions for HFNS are not yet widely accessible to women at work.
We hypothesized that CBT will be more effective than no treatment in (i) reducing the impact of HFNS (problem-rating), 11 and (ii) reducing HFNS frequency, moderating menopause beliefs, HFNS beliefs and behaviors, improving mood, sleep, work and social adjustment, and work outcomes (work absence, presenteeism, job performance, and turnover intention).
METHODS
The trial is reported in accordance with the CONSORT guidelines for randomized controlled trials 39 and is described in detail in a trial protocol paper 25 (trial registration: ClinicalTrials.gov identifier: NCT02623374).
Ethical approval was obtained from Kings College London Research Ethics Committee (Psychiatry, Nursing and Midwifery Research Ethics Subcommittee, reference: RESCMR-14/15-0475).
Participants and procedure
Eight organizations, from public and private sectors, participated in the study. Organizations volunteered to take part in response to talks given at conferences or other occupational health-related events, and by direct contact. Each participating organization had a ''gatekeeper'' who was responsible for disseminating recruitment materials (posters, leaflets, emails) within the organization. The research team also gave presentations within organizations to raise awareness of the project and invite eligible women, who self-referred, to take part.
Participants were postmenopausal women with problematic HFNS. Inclusion criteria were women, employed within participating organizations, English speaking, aged 45 to 60 years, having problematic HFNS for at least 2 months (scoring above 2 on the Hot Flush Rating Scale, 7 minimal frequency of 10 a week), and having no current major physical or mental health problems that would compromise participation.
Potential participants contacted the trial coordinator by telephone or email and were provided with a verbal description of the study, and if interested to proceed, were screened by telephone. Those eligible were sent a participant information sheet, consent form, and a baseline questionnaire, with a self-addressed and stamped envelope to return the signed and dated consent form and questionnaire. Data were collected at Kings College London and participating organizations. Participants who returned signed consent and baseline questionnaires were randomly allocated into one of two arms: treatment or control (Fig. 1) . Randomization was performed using Microsoft Excel with a ratio of 1:1, stratifying by recruiting center. Participants allocated to the treatment group were posted the SH booklet. Data entry was performed by a researcher blind to group allocation and statistical analysis by the trial statistician who was also blind to treatment condition.
Participants were asked to completed follow-up questionnaires at 6 and 20 weeks postrandomization. A prize draw of £50 Amazon voucher (or similar) was offered as an incentive to complete all three questionnaires. The participants in the SH-CBT arm were also invited to take part in an evaluation interview via telephone after returning the final followup questionnaire.
Intervention
The SH-CBT booklet was adapted from the self-help booklet used in the MENOS2 trial 27, 37 (see protocol paper 25 ). The booklet was adapted and shortened, with additional sections covering work stress and how to discuss menopause at work. Pilot work was conducted to assess the acceptability, content and format of the intervention and questionnaires, as well as the delivery method. We also explored potential barriers and difficulties for women using the SH-CBT intervention. Telephone interviews were conducted with working postmenopausal women (n ¼ 10) who had been sent the booklet from four of the participating organizations. Women noted that having the word menopause on the front cover might cause embarrassment and reduce use of the booklet. The preferred delivery of the self-help intervention and questionnaires was in paper form; although several mentioned that an online option might be preferred by some women. Feedback was addressed; modifications included adding content about how to have conversations with line managers at work, an infographic that can be given to a line manager when attempting to have the discussion, removal of the word menopause from the front page, and adding examples from work situations throughout the booklet. The final revised booklet and questionnaires were also reviewed by an advisory group (comprising working postmenopausal women, academic researchers, trade union representatives, employers) and minor amendments/corrections made.
The final SH-CBT intervention was an A5 sized, color booklet with instructions and four chapters (with information, exercises and homework tasks) to be completed over 4 weeks. 
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Chapters covered psychoeducation about menopause and HFNS, stress management, breathing/relaxation, and learning cognitive and behavioral strategies to help manage HFNS, stress, and sleep, with individual goal setting and weekly homework. A relaxation and breathing exercise was also provided on a CD, which was included with the booklet, together with an infographic. Participants in the no treatment waitlist control (NTWC) condition did not receive SH-CBT during the treatment phase but were sent the SH-CBT booklet after the 20-week assessment, off-trial. All participants were able to access their general practitioner and other health care options.
Measures
Demographic information (age, ethnicity, height, weight, education, relationship and employment status), smoking, alcohol intake and exercise behavior, menopause status (menopausal transition/postmenopause), treatment experience, and work variables (type of job, working hours, shift working, age and sex of work colleagues) were recorded at baseline. All data were self-reported.
Primary outcome
The primary outcome was HFNS Problem Rating 10 at 6 and 20 weeks postrandomization. Problem rating was measured by a subscale of the Hot Flush Rating Scale as used in the MENOS2 trial, 27 containing three items: ''To what extent do you regard your flushes/sweats as a problem?''; ''How distressed do you feel about your hot flushes?''; and ''How much do your hot flushes interfere with your daily routine?'' Items are measured on a 10-point scale ranging from 1 to 10, with high scores indicating more problematic hot flushes; a 2-point change on this scale is generally considered clinically significant. 27, 28 Cronbach alpha (a) for this measure was 0.83 at baseline.
Secondary outcomes
HF frequency: HFNS frequency was measured with the Hot Flush Rating Scale, 7 which records the number of HFNS experienced in the previous week.
HFNS beliefs and behaviors: A shortened version of the Hot Flush Belief Scale 40 and the Hot Flush Behaviour Scale 41 were used (see Supplementary file, http://links.lww.com/ MENO/A284). 25 Beliefs were measured using a mean score of 10 items, producing three subscales: beliefs about HF in a social context (at baseline, a¼0.89); coping/control over HF (a¼0.73); and beliefs about NS and sleep (a¼0.60). Behaviors were measured from a mean score of six items producing two subscales: avoidance behavior (at baseline, a¼0.80) and positive behaviors (a¼0.48). Responses ranged from 0 (strongly disagree) to 5 (strongly agree).
The Menopause Representations Questionnaire (MRQ) 42 was used to assess women's cognitive representations of menopause with respect to identity (attribution of symptoms to menopause), consequences, and control/cure. The MRQ comprising of 37 items, using a 5-point Likert scale ranging from strongly agree (5) to strongly disagree (1) . Mean scores on the subscales are calculated. Cronbach alpha for the subscales at baseline were identity 0.80, negative impact 0.74, new phase 0.67, relief 0.47, and control/cure 0.77. The Revised Women's Health Questionnaire (WHQ) 43 was used to measure perceptions of physical and emotional health. The revised WHQ has 23 items and has been found to have the same if not improved psychometric properties than the original in a recent study. 44 The following subscales examined in this study: anxiety/depression, well-being, somatic symptoms sleep problems, and memory/concentration (baseline a¼0.62, 0.66, 0.68, 0.62, 0.72, respectively).
A single-item measure of sleep quality was added from the Pittsburgh Sleep Quality Index (PSQI), 45 which is a self-rated questionnaire assessing sleep quality over a 1-month time interval using a 4-point Likert scale (1 ¼ ''Very bad'' to 4 ¼ ''Very good'').
The Work and Social Adjustment Scale (WSAS) 46 is a fiveitem scale used to measure functional impairment at home, work, and in social situations attributed to a specific problem (menopausal symptoms). Items are measured from 0 (no impairment) to 8 (very severely impaired) and summed to produce a final score out of 40 (a¼0.88).
Work-related outcomes
Absenteeism is the total number of days affected by work absence in the last 4 weeks attributed to menopause. The number of days off work due to symptoms, the number of days arrived to work late, and the number of days left work early due to their menopause were summed to create this variable.
Job performance was measured using a single item 5-point Likert scale, 1 (poor) to 5 (excellent) where participants were asked to rate their perceived performance in relation to others.
The Stanford Presenteeism Scale 47 was used to measure postmenopausal women's perceptions of being physically present at their jobs, but experiencing decreased productivity and below-normal work quality due to their menopause. Using six items, the average scores on a 5-point Likert-type scale, ranging from strongly disagree (1) to strongly agree (5), were calculated (a¼0.79). Higher scores suggest low perceived work impairment due to menopause.
Turnover intention was measured using an existing fouritem measure, 48 with 5-point Likert scales, to assess the employee's intention to leave the organization (a¼0.81). A higher score suggests a greater intention to leave the organization.
Any medical, nonmedical, and over the counter treatments used and health services accessed for menopause during the treatment phase (post randomization) were logged at the 20-week follow-up.
Analysis of additional variables: attitude to menopause at work, disclosure, job stress and job satisfaction, resilience, intention to reduce working hours or stop working because of menopause, will be reported elsewhere, together with a mediation analysis.
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Sample size
Based on previous studies, 27 ,28 a total sample size of 80 participants, 40 per arm, are required to detect 2 points difference in HFNS mean score at 6 weeks using regression analysis controlling for baseline level of the outcome, with a 90% power at 2-tailed significance 0.05 level, assuming equal SD (3.0) for both groups and correlation between baseline and follow-up measures at 0.4 for the purpose of being conservative. After taking into account 20% loss to follow-up rate, a total sample size of 100 is required, 50 per arm.
Statistical analysis
Group comparisons were carried out using the (modified) intention-to-treat principle, with participants providing data on at least one postrandomization assessment analyzed in the group to which they were randomized. Treatment effects for the primary (HFNS problem rating) and secondary outcomes were estimated using linear mixed models.
The postrandomization values of the outcome variables at 6 and 20 weeks were included as the outcome. Indicator variables for time, group, and a time by group interaction term and a recruiting center indicator variables were included as covariates to allow treatment effects to vary by group at the two postrandomization assessments. A random intercept for each participant was included to account for the repeated assessment of the outcome variable. Adjusted mean differences are presented unstandardized (ie, original scale units) and as a standardized mean differences (ie, standard deviation units; SMD) where the adjusted mean difference is divided by the pooled standard deviation of the outcome at baseline.
Before estimating the treatment effects, the suitability of the variables for analysis was considered by inspecting their distributions by group at each time point. Residual diagnostics were performed for the mixed-effects models to confirm the assumption that outcome variables follow an approximately normal distribution was not violated.
The maximal likelihood estimator employed produces unbiased and efficient estimates of the treatment effect when missing outcome data arises at random conditional on the covariates included (ie, missing at random). Sensitivity analyses were performed by comparing the treatment effect estimates to those where missing outcome assessments were imputed using the last observed value of the outcome (ie, last observation carried forward). In addition, for the primary outcome, additional sensitivity analysis was performed using a pattern-mixture model approach to determine the impact of a range of reasonable missing data scenarios on the treatment effect estimate. 49 The recorded evaluation interviews were transcribed and a thematic content analysis was performed using the software NVivo (version21). Categories were developed under four main themes, including the impact of the intervention, reasons for the impact and for no impact experienced, perceptions of the intervention's content and delivery, and suggestions for improvement.
RESULTS
Participants
A total of 124 participants were randomized from 8, public (n ¼ 6) and private sector (n ¼ 2), organizations in the United Kingdom. Of these, 106 (85.5%) completed at least one postrandomization assessment and were included in the (modified) intention-to-treat analysis. Overall attrition was below 20%, but it was higher in the SH-CBT group compared with the NTWC group with 60 (93.8%) and 46 (76.7%) included in the analysis, respectively. Participant flow through the trial is shown in Figure 1 . Table 1 presents demographic information at baseline. Women were, on average, 54 years old and 70% were of white ethnicity. The sample was fairly healthy, with the majority rating their general health as good to excellent (85%). Over two-thirds were nonsmokers and were drinking less than 7 units of alcohol per week. Most women exercised at least twice a week (68%). Women generally did not have a current mental or physical health problem (85%), nor were receiving treatment for breast cancer (95%). They had experienced their last menstrual period (LMP) on average 4 years before entering the study. Four percent (n ¼ 5) were taking HT, and 18% (n ¼ 20) were prior HT users; 32.5% (n ¼ 40) were taking over the counter remedies or medication for menopause and 23% (n ¼ 29) had sought medical help for menopause in the past 6 months.
Just over three-quarters (83%) of women worked full-time, with regular hours, not shift work. The majority worked in nonmanual jobs (82%), with both male and female colleagues (65%) having a mixed age range (73%). At baseline, the number of days affected by absence (including whole days, arriving to work late, leaving work early), that women attributed to menopause averaged 2 days (mean ¼ 1.80, SD ¼ 4.22) at baseline, over the past 4 weeks. Half (50.8%, n ¼ 63) had disclosed that they were going through menopause to a line manager, but only 9.7% (n ¼ 12) disclosed that menopause was a reason for any work absence. The majority rated their work performance as very good or excellent (79.9%, n ¼ 91).
Outcomes
At baseline women reported having an average of 56.24 (range 0-245) HFNS per week, and these were rated as problematic (mean 6.5/10); the average duration of HFNS was 35 (SD ¼ 32.6) months (range 2-192 mo).
Primary outcome
Unadjusted and baseline adjusted mean differences are shown in Table 2 . The adjusted mean difference in the primary outcome HFNS Problem-rating, controlling for baseline level, was À1.49 (P < 0.001) in favor of the SH-CBT group at 6 weeks, and À1.09 (P < 0.01) at 20 weeks. These differences translate to a moderate to large effect sizes of d ¼ À0.77 and À0.56, respectively (Table 2 and Fig. 2) .
No selection bias due to differential attrition by baseline problem rating was apparent. There was only a small HARDY ET AL difference in HFNS Problem-rating mean baseline scores in the NTWC group between those completing (N ¼ 60) and not completing (N ¼ 4) at postrandomization assessment, and therefore included in the analysis: 6.80 versus 7.33. Similarly, there was only a small difference in baseline scores in the SH-CBT group between those completing (N ¼ 46) and not completing (N ¼ 14) a postrandomization assessment: 6.25 versus 6.10. Those who did not complete were significantly more likely to be of nonwhite ethnicity (Pearson chi-square ¼ 4.38, P < 0.05), not in a relationship (chisquare ¼ 5.61, P < 0.05) and to score higher on HFNS avoidance behavior (mean rank ¼ 85.89) to those included (mean rank ¼ 58.53), U ¼ 1,375, z ¼ À3.056, P < 0.01, and not receiving treatment for any major physical or health problem (chi-square ¼ 6.63, P < 0.01). There were no significant differences in HFNS frequency or problem rating.
Sensitivity analysis was conducted to determine the impact of missing data at postrandomization assessments on the estimated treatment effect size at 6 weeks. The last observation carried forward approach including all randomized participants indicated a more conservative effect size of 0.51. A pattern-mixture model approach was used to examine the sensitivity of the treatment effect as a result of the higher attrition in the SH-CBT group. This suggested that those with missing data in the intervention group would have had to experience worsening of 3 points on average relative to their baseline values to reduce the treatment effect to nonsignificant. Such a difference seems implausible.
Secondary outcomes
In addition to the significant moderate to large effect on the primary outcome, there was a significant effect on HFNS frequency at the 6-and the 20-week assessment, effect sizes 0.39 and 0.31, respectively. HFNS frequency was highly variable; total HFNS frequency reduced on average by 24% SH-CBT, 0.5% NTWC at 6 weeks, and by 35.5% SH-CBT and 15% for NTWC at 26 weeks.
There was a significant effect of SH-CBT on levels of functioning measured by the Work and Social Adjustment Scale (WSAS) 46 at both 6-and 20-week assessments. There were significant group differences in WHQ well-being and somatic symptom scores at 20 weeks, and in sleep problems at 6 and 20 weeks. Similarly, significant improvements in sleep quality were recorded at 6 and 20 weeks as assessed by the Pittsburg Sleep Quality Index 45 (see Table 2 and Fig. 2 ). Large and moderate significant effects were observed for the beliefs about menopause and beliefs/behaviors about HFNS. SH-CBT participants viewed menopause as more controllable and curable and as a new phase (MRQ control/cure and new phase subscales) significantly more than NTWC at both 6-and 20-week assessments. Effects on other MRQ subscales were small and generally nonsignificant. Moderate to large significant effects were observed for the three HFNS beliefs scales and for the positive behaviors subscale. The effect on avoidant behaviors was small and nonsignificant.
In relation to work variables, effects were generally small and nonsignificant for absence (days affected by any absence in the past 4 weeks and attributed to menopause including whole days, arriving to work late, leaving work early), performance, and turnover intention. However, for presenteeism (Stanford Presenteeism Scale 47 ) at 20 weeks, the effect of SH-CBT compared to NTWC was significant and approaching a large effect size (Fig. 3) . Those receiving SH-CBT had higher scores at 20 weeks than the NTWC group, indicating lower perceived work impairment due to menopause for the SH-CBT group.
Use of services and medication
Since starting the study (randomization to 20-wk assessment), 14% (n ¼ 6) of the SH-CBT and 15% (n ¼ 9) of the NTWC participants had sought medical help, on average once, for menopause symptoms-a nonsignificant difference. One woman (SH-CBT group) was prescribed antidepressants for anxiety/mood swings; in the NTWC group, two were prescribed HT, one the contraceptive pill and two changed type of HT. Eight (NTWC ¼ 7, SH-CBT ¼ 1) had used nonmedical or herbal treatments since starting the study: homeopathy (n ¼ 1 NTWC), evening primrose oil (n ¼ 3 NTWC), red clover (n ¼ 1 NTWC), sage tablets (n ¼ 1 NTWC), and Menopace (one participant from each group).
Adherence and acceptability
At the 6-week follow-up assessment, 61% (n ¼ 27) of SH-CBT participants had read the entire self-help booklet, and an additional 21% (n ¼ 9) more than half. The majority (82%, n ¼ 32) had used the relaxation/breathing exercise at least 1 to 2 times a week or more, at the onset of a hot flush (82%, n ¼ 37) and to help manage a stressful situation at work (71%, n ¼ 25). Similarly, at 20 weeks, 65% (n ¼ 28) of SH-CBT participants had read all of the self-help booklet, and 26% (n ¼ 11) more than half. Relaxation/breathing was reportedly still being used by 79% (n ¼ 33) at least 1 to 2 times a week or more.
At 6 weeks 89.4% (n ¼ 42) rated the self-help booklet as being helpful in coping with their menopause symptoms at work; 23.4% (n ¼ 11) moderately and 31.9% (n ¼ 15) very/ extremely helpful. At the 20-week assessment 88.1% (n ¼ 35) rated the self-help booklet as helpful in coping with their menopause symptoms at work; 26.2% (n ¼ 11) moderately and 45.2% (n ¼ 19) very/extremely helpful.
Evaluation interviews
Twenty-seven women were interviewed at the end of the trial from the intervention group. We originally intended to select 50% of transcripts for analysis, 22 but as only 27 women took part in interviews, all their data were included. The majority, 82%, felt that the intervention had impacted positively on their experience of HFNS, 48% mentioning a reduction specifically in HFNS frequency. Positive benefits were reported to life in general (63%), and to working life (52%). Since the start of the trial, 37% had talked about their menopause to their line manager.
Reasons given for improvements in general to life included: changing perceptions about menopause and having a better understanding, exercising self-care, and having the confidence to talk and to be open about their menopause. Positive changes to working life were attributed to addressing HFNS triggers identified during the SH-CBT, feeling less bothered or focused on symptoms, using the breathing techniques and 
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letting go, and also having more confidence at work. Participants who did not experience any impact from the intervention stated it was because they were already doing things to help manage symptoms anyway they did not follow the selfhelp or their HFNS had improved.
In terms of the self-help booklet content, the main aspects that the participants mentioned as being helpful, were that it was informative, particularly the materials on managing HFNS, for example, addressing thoughts, the CBT approach, and identifying triggers; they also liked the dairies and interactive elements of the booklet (eg, exercises to complete). Other helpful aspects included having testimonials and perceptions of others presented in the booklet, the breathing exercise and CD, the goal setting section, as well as the general design and structure of the booklet. Approximately two thirds liked the hard-copy format of the booklet; however, some thought that having an online version or an app for smart phones could be offered in the future.
DISCUSSION
The aim of this multicenter study was to investigate the impact of a brief, unguided, self-help CBT intervention on HFNS, for women having problematic menopausal symptoms in the work context. When compared to a no-treatment control group, unguided self-help CBT significantly reduced HFNS problem rating with moderate to large effect sizes and improvements were maintained at 20 weeks postrandomization. These results are consistent with findings from previous randomized controlled trials of CBT for HFNS, when delivered in-group and guided self-help booklet formats. [27] [28] [29] [30] However, it is noteworthy that this study implemented a considerably briefer version of SH-CBT with no additional support, and in a work, rather than a clinical context. HFNS frequency also reduced at both time points and group differences were significant at both 6 and 20 weeks. Percentage reduction in frequency of 24% (6 wk) and 35.5% (20 wk) was broadly similar to that found in previous studies of guided self-help; 27, 30 relatively small changes were evident for the NTWC group. In the MENOS2 trial 27 HFNS frequency assessed by sternal skin conductance monitoring also significantly improved after CBT, suggesting that changes might occur at both subjective and physiological levels. 35 The significant improvements on the Work and Social Adjustment Scale (WSAS) scores at both 6 and 20 weeks postrandomization compared with the control group, provide evidence of the secondary benefits of SH-CBT to functioning at work, home, leisure, and in social situations. The WSAS is routinely used in primary care psychology services in the United Kingdom and has been found to reflect a distinct social functioning factor and to be sensitive to treatment effects. 50 There were significant group differences in well-being and somatic symptoms at 20, but not at 6, weeks, but not anxiety/ depression nor memory/concentration subscales of the Revised WHQ. However, WHQ sleep problems subscales scores and sleep quality significantly improved after SH-CBT at 6 and 20 weeks. The CBT intervention includes advice and strategies to improve sleep and CBT is an effective treatment for insomnia. 51 CBT for HFNS targets cognitions (catastrophic or shameful thoughts in social contexts, worries about the consequences of night-time wakening), overly negative beliefs about menopause, behavioral reactions, and stress/well-being. Mediation analyses of previous trials have shown that CBT seems to work by changing symptom perceptions and cognitive appraisals (women's perceptions, attitudes and beliefs about menopause and symptoms) as well as using helpful behavioral strategies. 33, 34 Consistent with this work, we found significant changes in beliefs and behaviors about HFNS after SH-CBT, suggesting that the treatment is targeting relevant cognitions and behaviors. More general beliefs about menopause, reflected in MRQ subscales negative impact, control/cure, and new phase subscales, also showed significant between group differences at both 6-and 20-week assessments.
The current findings therefore lend support to the cognitive model of HFNS. 31 The social aspects of these beliefsrelating to social meanings about menopause and concern about other people's views when having hot flushes-are relevant because women report embarrassment and fear of ridicule particularly in work contexts. 10, 12, 13 More positive/ neutral beliefs about menopause, for example, that symptoms are controllable and that menopause can herald a new life phase, are associated with more positive and helpful beliefs about HFNS, for example, that others may not think negatively about them, that women have strategies to cope with them; and, in turn, positive and neutral beliefs about HFNS are associated with less problematic HFNS. 32, 40, 41 The majority of women (80%) rated their work performance as very good or excellent at baseline. Presenteeism, using the Stanford Presenteeism Scale, 45 measures postmenopausal women's perceptions of productivity and work impairment due to their menopause while being physically present at work. Higher scores suggest low perceived work impairment due to menopause; that is, women are at work and managing any work impairment so that their performance is not affected. The SH-CBT group obtained significantly higher scores than NTWC at 20 weeks. It is possible therefore that the strategies learned from the SH-CBT might enable women to manage their HFNS so that they have less impact on their work. HFNS become less problematic and social and work functioning improves. The relationships between improvements in HFNS and presenteeism will be explored in a future publication.
The lack of impact on additional work outcomes may relate to the timeframes used in the trial. It is possible that 20 weeks postrandomization, or approximately 16 weeks posttreatment, was insufficient time for changes in work adjustment to occur. For example, the significant between group difference in presenteeism was only found at 20 weeks and not at 6 weeks.
Alternatively, problematic HFNS may not impact on all work outcomes in similar ways. The workplace is a complex environment; the experience of HFNS may interact with several employee related and work-related factors. A review HARDY ET AL by Jack et al 22 identified that the work environment, both physical and psychosocial, may influence women's experience of menopause. Further analysis of the potential moderating effect of a number of work related factors (work environment, job satisfaction, and job stress) is planned.
Overall, our results suggest that an unguided, self-help CBT approach may be efficacious as a low intensive treatment option for working women with problematic menopause symptoms. The levels of frequency and problem-rating HFNS at baseline were very similar to the levels of well women and breast cancer patients recruited into clinical trials, [27] [28] [29] and the improvements after this low-intensity version of SH-CBT were robust and sustained. Comparable recommended nonhormonal treatments for HFNS involve several sessions of treatment, for example, 5 to 12 sessions of hypnosis and 8 sessions of mindfulness: 36 while hormonal and nonhormonal medical treatments involve appointments and ongoing prescription charges. The intervention involves no health professional time and is likely therefore to be cost effective; however, a health economic analysis is recommended. The intervention appeared to be acceptable in terms of feedback reported during interviews, and the women's reports on what was helpful were consistent with qualitative data collected during the MENOS2 trial. 52 
Strengths and limitations
The trial was adequately powered, there were no adverse events, relatively low levels of attrition during the trial period, and adherence to the SH-CBT was reasonable. The SH-CBT was piloted and modified in response to feedback. Unexpectedly, dropouts were higher in the SH-CBT than the NTWC group which is a limitation. Most women in the SH-CBT arm who dropped out reported time pressures as the main problem for not completing the self-help intervention and questionnaires. It is possible that the women in the NTWC arm may have been more likely to persist in the study because they were expecting to obtain the SH-CBT off trial at the end of the study. Participants who dropped out were more likely to be nonwhite, not in a relationship, to have higher baseline HFNS avoidance behavior scores, and not having any current treatment for any major physical or mental health problem. In previous trials, ethnicity either did not moderate the effects of CBT, 34 or when it did it was women of non-white ethnicity who were more likely to benefit from CBT. 33 It is possible that the self-help booklet was less appealing or acceptable to some women, who may have had less support, and, for others, being avoidant about HFNS could reflect a more general strategy (ie, avoiding the self-help book designed to help manage HFNS). Pilot work was conducted to assess the acceptability, content and format of the intervention and questionnaires, as well as the delivery method, and adjustments made, but we did not actively target women from a range of ethnic groups. Further exploration is needed into the acceptability of the booklet, its format, and the level of individual or group support in different organizations, to increase adherence to the intervention.
Assessment of work outcomes relied on subjective rather than objective measures. However, obtaining formal sickness absence data and standard measurements of job performance for different job roles in heterogeneous workplaces is a complex matter and was beyond the scope of this study. Furthermore, this might have been perceived, by participants, as compromising the anonymous nature of their responses.
Implications and future research
The trial findings have implications for various key stakeholders; employers, occupational health professionals, trade union representatives, and other professionals with a role in workplace health and well-being, may wish to make self-help CBT available to staff who have bothersome menopause symptoms. Similarly, policy makers should ensure that sufficient awareness and provision of information and help is offered to staff who may be experiencing menopause-related difficulties at work, in line with recent recommendations. 1, [3] [4] [5] 53 Several suggestions for future research have been mentioned above. The format and level of detail of the provision of information for working women could be considered in future research; for example, whether briefer information is made available for all staff, with SH-CBT offered to those who have problematic symptoms. The needs and working environments of organizations are likely to vary. SH-CBT is available in book format 37 and workshops or groups could be offered using the manual for health professionals. 38 It may also be of interest to explore the effect of self-help for other symptoms reported by women at work (eg, confidence, fatigue) in more detail, and to clarify the extent to which these are affected by, or interact with, for example, work stress and HFNS. Recommendations for improving the experience of menopause at work include changes at an individual level and at an organizational level. [3] [4] [5] Similarly, we would predict that the SH-CBT intervention for women with troublesome menopausal symptoms might be more effective when offered in the context of a broader strategy to improve awareness about menopause in general, to reduce stigma and to make appropriate changes to the work environment. 53 
CONCLUSIONS
To our knowledge this is the first study to develop and evaluate an unguided, self-help intervention specifically to help postmenopausal women to manage HFNS in the workplace. The results suggest that SH-CBT is an effective and acceptable low-intensity, nonmedical intervention for problematic HFNS that has additional effects on work and social adjustment and on presenteeism. The study is timely, and has important implications for employers and other stakeholders who have a responsibility to provide resources for working women.
